[Coronary artery bypass grafting in the elderly: early results]

Tomasz Łapiński1, Bronisław Czech, Barbara Bień

  • 1Klinika Kardiochirurgii Akademii Medycznej w Białymstoku. tomlap@piasta.pl

Przeglad Lekarski
|August 20, 2002
PubMed

Insights

For elderly patients undergoing coronary artery bypass grafting (CABG), chronological age may be less important than biological factors for assessing operative risk. This study found similar mortality and morbidity rates between older and younger CABG patients.

Area of Science:

  • Cardiovascular Surgery
  • Geriatric Medicine
  • Health Outcomes Research

Context:

  • Coronary artery bypass grafting (CABG) indications are increasing due to an aging global population.
  • Existing literature lacks consensus on accurately estimating operative risk for elderly patients undergoing CABG.
  • This study addresses the need for better risk stratification in older adults undergoing cardiac surgery.

Purpose:

  • To retrospectively analyze postoperative mortality and morbidity in elderly versus younger patients undergoing CABG.
  • To compare operative risk assessment using the EuroSCORE protocol between age groups.
  • To identify independent risk factors for adverse outcomes in elderly CABG patients.

Summary:

  • A retrospective analysis of 300 patients (103 over 65, 197 younger) undergoing CABG was performed.
  • Operative risk, assessed by EuroSCORE, was higher in the elderly group, but mortality and morbidity rates were similar between groups.
  • Independent risk factors for elderly patients included female gender and gastrointestinal bleeding; diabetes mellitus was a probable contributor to mortality.

Impact:

  • Findings suggest biological age, rather than chronological age, is crucial for CABG eligibility in the elderly.
  • This research may inform clinical decision-making regarding surgical risk assessment for older adults.
  • Highlights the need for individualized risk evaluation in geriatric cardiac surgery patients.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...